Fidelity Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.85B | Buy |
|
|||||
|
2025
Q2 | $2.34B | Buy |
|
|||||
|
2025
Q1 | $2.33B | Buy |
|
|||||
|
2024
Q4 | $1.79B | Buy |
|
|||||
|
2024
Q3 | $1.19B | Buy |
|
|||||
|
2024
Q2 | $1.03B | Buy |
|
|||||
|
2024
Q1 | $1.05B | Buy |
|
|||||
|
2023
Q4 | $718M | Buy |
|
|||||
|
2023
Q3 | $656M | Buy |
|
|||||
|
2023
Q2 | $599M | Buy |
|
|||||
|
2023
Q1 | $551M | Buy |
|
|||||
|
2022
Q4 | $526M | Buy |
|
|||||
|
2022
Q3 | $414M | Sell |
|
|||||
|
2022
Q2 | $766M | Buy |
|
|||||
|
2022
Q1 | $737M | Sell |
|
|||||
|
2021
Q4 | $783M | Buy |
|
|||||
|
2021
Q3 | $660M | Buy |
|
|||||
|
2021
Q2 | $676M | Sell |
|
|||||
|
2021
Q1 | $612M | Sell |
|
|||||
|
2020
Q4 | $712M | Sell |
|
|||||
|
2020
Q3 | $744M | Sell |
|
|||||
|
2020
Q2 | $814M | Buy |
|
|||||
|
2020
Q1 | $737M | Buy |
|
|||||
|
2019
Q4 | $905M | Sell |
|
|||||
|
2019
Q3 | $828M | Buy |
|
|||||
|
2019
Q2 | $731M | Buy |
|
|||||
|
2019
Q1 | $729M | Sell |
|
|||||
|
2018
Q4 | $673M | Sell |
|
|||||
|
2018
Q3 | $766M | Buy |
|
|||||
|
2018
Q2 | $756M | Sell |
|
|||||
|
2018
Q1 | $741M | Sell |
|
|||||
|
2017
Q4 | $698M | Sell |
|
|||||
|
2017
Q3 | $808M | Sell |
|
|||||
|
2017
Q2 | $1.08B | Buy |
|
|||||
|
2017
Q1 | $996M | Buy |
|
|||||
|
2016
Q4 | $815M | Sell |
|
|||||
|
2016
Q3 | $924M | Buy |
|
|||||
|
2016
Q2 | $897M | Buy |
|
|||||
|
2016
Q1 | $647M | Buy |
|
|||||
|
2015
Q4 | $553M | Buy |
|
|||||
|
2015
Q3 | $438M | Buy |
|
|||||
|
2015
Q2 | $457M | Sell |
|
|||||
|
2015
Q1 | $575M | Buy |
|
|||||
|
2014
Q4 | $484M | Buy |
|
|||||
|
2014
Q3 | $444M | Buy |
|
|||||
|
2014
Q2 | $347M | Sell |
|
|||||
|
2014
Q1 | $352M | Sell |
|
|||||
|
2013
Q4 | $360M | Sell |
|
|||||
|
2013
Q3 | $518M | Sell |
|
|||||
|
2013
Q2 | $579M | Buy |
|